Manuel Muñoz Torres

Summary

Publications

  1. doi Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate
    Manuel Muñoz-Torres
    Bone Metabolic Unit, Endocrinology Division, University Hospital San Cecilio, Granada, Spain
    Maturitas 64:188-92. 2009
  2. doi [Medical treatment of primary hyperparathyroidism: role of calcimimetics]
    Manuel Muñoz Torres
    Unidad de Metabolismo Oseo, Servicio de Endocrinologia y Nutricion, RETICEF, Hospital Universitario San Cecilio, Granada, Espana
    Endocrinol Nutr 56:29-34. 2009
  3. doi [Hypophosphatasia: new therapeutic approaches]
    Guillermo Alonso
    Unidad de Metabolismo Oseo, Servicio de Endocrinologia y Nutricion, RETICEF, Hospital Universitario San Cecilio, Granada, Espana
    Med Clin (Barc) 132:108-11. 2009
  4. ncbi Lactose intolerance revealed by severe resistance to treatment with levothyroxine
    Manuel Muñoz-Torres
    Department of Endocrinology, Hospital Universitario San Cecilio de Granada, Granada, Spain
    Thyroid 16:1171-3. 2006
  5. ncbi Calcitonin therapy in osteoporosis
    Manuel Muñoz-Torres
    Bone Metabolic Unit, Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain
    Treat Endocrinol 3:117-32. 2004
  6. ncbi [Advances in ostheochlast biology: the osteoprotegerin-RANK ligand system]
    Manuel Muñoz-Torres
    Unidad de Metabolismo Oseo Servicio de Endocrinología y Nutrición Hospital Universitario San Cecilio Granada España
    Med Clin (Barc) 122:75-7. 2004
  7. ncbi Susceptibility for postmenopausal osteoporosis: interaction between genetic, hormonal and lifestyle factors
    Pedro Mezquita-Raya
    Endocrinology Division, Hospital Torrecardenas, Almeria, Spain
    Calcif Tissue Int 75:373-9. 2004
  8. ncbi [Prevalence of vitamin D deficiency in populations at risk for osteoporosis: impact on bone integrity]
    Pedro Mezquita Raya
    Area de Metabolismo Oseo, Servicio de Endocrinología Facultad de Medicina, Hospital Universitario San Cecilio, Granada, Spain
    Med Clin (Barc) 119:85-9. 2002
  9. ncbi Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study
    Manuel Sosa
    University of Las Palmas de Gran Canaria, Investigation Group on Osteoporosis, Hospital University Insular, Bone Metabolic Unit, Las Palmas de Gran Canaria, Canary Islands, Spain
    Aging Clin Exp Res 21:27-32. 2009
  10. doi Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis
    Rebeca Reyes-García
    Bone Metabolic Unit, Endocrinology Division, San Cecilio University Hospital, Granada, Spain
    Menopause 17:140-4. 2010

Collaborators

  • Rebeca Reyes-García
  • Nuria Guanabens
  • Manuel Sosa
  • Manuel Muñoz-Torres
  • Guillermo Alonso
  • Pedro Mezquita-Raya
  • Mariela Varsavsky
  • Fernando Escobar-Jimenez
  • Maria Estrella Ruiz-Requena
  • Pedro Mezquita Raya
  • Juan De Dios Luna
  • Diego Fernández-García
  • Fernando Luque-Recio
  • Juan Dios de Luna
  • Diego Fernández García
  • Mezquita Pedro Raya
  • Jose Manuel Quesada
  • Magdalena de la Higuera López-Frías
  • Francisca Lopez-Rodriguez
  • Gabriel Dorado
  • Fernando Escobar Jiménez
  • Nuria Martínez Martín
  • Alicia Conde Valero
  • Enrique Raya Alvarez
  • Francisca Lopez Rodriguez
  • Norberto Ortego Centeno
  • Juan de Dios Luna Jd
  • Jorge González Calvín

Detail Information

Publications10

  1. doi Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate
    Manuel Muñoz-Torres
    Bone Metabolic Unit, Endocrinology Division, University Hospital San Cecilio, Granada, Spain
    Maturitas 64:188-92. 2009
    ..Measurement of circulating levels of cathepsin K may be useful to assay the number or function of osteoclasts...
  2. doi [Medical treatment of primary hyperparathyroidism: role of calcimimetics]
    Manuel Muñoz Torres
    Unidad de Metabolismo Oseo, Servicio de Endocrinologia y Nutricion, RETICEF, Hospital Universitario San Cecilio, Granada, Espana
    Endocrinol Nutr 56:29-34. 2009
    ..The exact role of calcimimetics in the overall management of PHPT is promising and should be considered in future clinical practice guidelines...
  3. doi [Hypophosphatasia: new therapeutic approaches]
    Guillermo Alonso
    Unidad de Metabolismo Oseo, Servicio de Endocrinologia y Nutricion, RETICEF, Hospital Universitario San Cecilio, Granada, Espana
    Med Clin (Barc) 132:108-11. 2009
    ....
  4. ncbi Lactose intolerance revealed by severe resistance to treatment with levothyroxine
    Manuel Muñoz-Torres
    Department of Endocrinology, Hospital Universitario San Cecilio de Granada, Granada, Spain
    Thyroid 16:1171-3. 2006
    ..The possibility of correcting this disorder with simple dietary measures justifies its consideration...
  5. ncbi Calcitonin therapy in osteoporosis
    Manuel Muñoz-Torres
    Bone Metabolic Unit, Endocrinology Division, Hospital Universitario San Cecilio, Granada, Spain
    Treat Endocrinol 3:117-32. 2004
    ....
  6. ncbi [Advances in ostheochlast biology: the osteoprotegerin-RANK ligand system]
    Manuel Muñoz-Torres
    Unidad de Metabolismo Oseo Servicio de Endocrinología y Nutrición Hospital Universitario San Cecilio Granada España
    Med Clin (Barc) 122:75-7. 2004
    ..osteopetrosis) in animal models. Further studies with these factors will provide the development of drugs to treat osteoporosis and other metabolic bone diseases...
  7. ncbi Susceptibility for postmenopausal osteoporosis: interaction between genetic, hormonal and lifestyle factors
    Pedro Mezquita-Raya
    Endocrinology Division, Hospital Torrecardenas, Almeria, Spain
    Calcif Tissue Int 75:373-9. 2004
    ..Our study shows that COLIA1 Sp1 polymorphism, S-25OHD and s-IGF-I serum levels and physical activity are independently associated with BMD in postmenopausal Spanish women...
  8. ncbi [Prevalence of vitamin D deficiency in populations at risk for osteoporosis: impact on bone integrity]
    Pedro Mezquita Raya
    Area de Metabolismo Oseo, Servicio de Endocrinología Facultad de Medicina, Hospital Universitario San Cecilio, Granada, Spain
    Med Clin (Barc) 119:85-9. 2002
    ....
  9. ncbi Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study
    Manuel Sosa
    University of Las Palmas de Gran Canaria, Investigation Group on Osteoporosis, Hospital University Insular, Bone Metabolic Unit, Las Palmas de Gran Canaria, Canary Islands, Spain
    Aging Clin Exp Res 21:27-32. 2009
    ..Type 2 diabetes mellitus (DM) has a high prevalence in aging obese postmenopausal women. It is not clear whether or not diabetes produces an increase in bone mineral density or an increase in fracture rates...
  10. doi Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis
    Rebeca Reyes-García
    Bone Metabolic Unit, Endocrinology Division, San Cecilio University Hospital, Granada, Spain
    Menopause 17:140-4. 2010
    ....